Stephens Consulting’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,300
Closed -$14.1K 861
2025
Q2
$14.1K Sell
2,300
-50
-2% -$333 ﹤0.01% 300
2025
Q1
$17.9K Buy
2,350
+50
+2% +$418 ﹤0.01% 267
2024
Q4
$22.1K Hold
2,300
0.01% 267
2024
Q3
$13.6K Hold
2,300
﹤0.01% 303
2024
Q2
$15.9K Hold
2,300
﹤0.01% 289
2024
Q1
$17.7K Hold
2,300
0.01% 261
2023
Q4
$20.2K Sell
2,300
-400
-15% -$2.93K 0.01% 248
2023
Q3
$19.7K Sell
2,700
-1,000
-27% -$7.45K 0.01% 243
2023
Q2
$24.5K Hold
3,700
0.01% 228
2023
Q1
$12.6K Hold
3,700
0.01% 291
2022
Q4
$10.3K Hold
3,700
0.01% 295
2022
Q3
$10.6K Hold
3,700
0.01% 324
2022
Q2
$12.8K Hold
3,700
0.01% 292
2022
Q1
$17.4K Sell
3,700
-200
-5% -$978 0.01% 286
2021
Q4
$23.6K Buy
+3,900
New +$27.1K 0.02% 280

Other funds holding MDXG

Stephens Consulting's MDXG Position: Q3 2025 in Review

Stephens Consulting sold out of MiMedx Group (MDXG) in Q3 2025, closing a stake of 2,300 shares — an estimated $14.1K sold.

Stephens Consulting first reported a position in MDXG in Q4 2021 and held it in 15 quarters. The position peaked at $24.5K in Q2 2023. 231 funds tracked by Wall St. Rank hold MDXG as of Q3 2025.

  • Stephens Consulting reported no remaining MiMedx Group position as of Q3 2025 after selling out during the quarter.
  • Stephens Consulting sold 2,300 MiMedx Group shares in Q3 2025, an estimated $14.1K.
  • Stephens Consulting first reported a position in MiMedx Group in Q4 2021 and held it in 15 quarters.
  • Stephens Consulting's MiMedx Group position peaked at $24.5K in Q2 2023.
  • 231 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2025.

Based on Stephens Consulting's 13F filing for Q3 2025, filed 15 Oct 2025.